• Home
  • Randomize
  • Aim and mission
  • News
  • Newsletters
  • Contact
  • Organization (investigators, collaborators and funders)
  • Data requests
    • Publication policy CONTRAST
    • DATA REQUEST FORM (internal parties)
    • DATA REQUEST FORM (external parties)
  • Work packages info
    • WP1: Improving microvascular reperfusion
    • WP2: MR ASAP
    • WP3A: MR CLEAN LATE
    • WP3B: MR CLEAN MED
    • WP3C: MR CLEAN NO-IV
    • WP4: Dutch ICH pilot
    • WP5: Biobank
    • WP6: Clinical data management
    • WP7: Imaging data management
    • WP8: Logistics and epidemiology
    • WPYT: Young talent program
  • Investigators
    • Randomize for MR CLEAN NO-IV
    • Randomize for MR CLEAN-LATE
    • Randomize for MR CLEAN-MED
    • Include for Dutch ICH pilot
    • Access to Open Clinica
    • Access to XNAT
    • Newsletter
    • CONTRAST PLAZA
  • Documents
  • Ongoing Trials
    • CASES
      • Randomization
      • Rationale and aim
      • Study design
      • Trial organization (investigators, collaborators and funders)
      • Trial protocol and trial documents
      • Trial progress
      • NEWS
      • Contact
      • Ontslaggegevens/discharge data
      • Links
      • FAQ
  • Closed trials
  • Links


MR CLEAN-MED

WP Leaders: Aad van der Lugt (Erasmus MC) and Diederik Dippel (Erasmus MC)

Aim: To assess the safety and effect of unfractionated heparin and platelet inhibitors, alone or in combination, in patients with acute ischemic stroke, wo undergo endovascular treatment for a confirmed anterior circulation occlusion.

Click here for the MR CLEAN-MED website